- Women with an especially deadly type of breast cancer who received a treatment regimen containing an experimental AbbVie Inc drug prior to surgery are likely to have a significantly better response than those who get a standard chemotherapy regimen, according to data from a clinical trial.
NEW YORK - Aetna Inc has decided not to reinstate or extend individual health insurance plans that are being canceled with the advent of the U.S. Affordable Care Act because the time frame is too short.
SACRAMENTO, California - Public health officials in California said on Thursday they had sought permission from the federal government to use a vaccine not approved for use in the United States against an outbreak of meningococcal disease among students in a public university.
- Aveo Oncology said its lead experimental drug was unlikely to succeed in a mid-stage colon cancer study that was testing if the drug was superior to an approved treatment.
COPENHAGEN - The potential for Grastek, an oral allergy drug made by Denmark's ALK Abello and American partner Merck, will depend on the product's label and price in the United States, chief executive Jens Bager told Reuters on Friday.
- A new type of diabetes drug from Bristol-Myers Squibb and AstraZeneca has been endorsed by U.S. medical experts, two years after it was rejected by regulators because of safety concerns.
LONDON - Serco will take a 17-million-pound ($28 million) exceptional charge this year related to three loss-making contracts in its UK clinical health business, the British outsourcing company said on Friday.
LONDON - Novartis said on Friday it was recalling some batches of its Tixylix liquid cough and cold medicines for children because of a potential manufacturing defect that could result in small pieces of plastic being found in the bottles.
- A panel of experts advising the U.S. Food and Drug Administration said an oral drug made by Merck & Co was effective in treating grass pollen allergy but expressed concerns about the drug's safety in children.
NEW YORK (Reuters Health) - People with an irregular heartbeat may also be at increased risk of being depressed, suggests a new study from Germany.